Condition
Gastric/Gastroesophageal Junction Adenocarcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Gastric/Gastroesophageal Junction Adenocarcinoma clinical trials that are recruiting, at sites in 9 countries (most in China (3), Australia (1), Canada (1)). By phase: Phase 2 (3), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 9Countries
Newest Gastric/Gastroesophageal Junction Adenocarcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| IBI343 in combination with chemotherapy for CLDN18.2-positive gastric cancer and pancreatic cancer | Phase 2 | Hangzhou, Zhejiang | Recruiting | Mar 19, 2026 |
| Combining Fruquintinib with chemotherapy for treating gastric cancer after surgery | Phase 2 | Zhengzhou | Recruiting | Jan 14, 2025 |
| Combining paclitaxel, apatinib, and adebrelimab for advanced gastric cancer treatment | Phase 2 | Fuzhou, Fujian | Recruiting | May 16, 2024 |
| Testing BMS-986340 alone and with other treatments for advanced solid tumors | Phase 1/2 | Clovis, California and 46 other locations | Recruiting | May 20, 2021 |
All recruiting trials (4)
-
IBI343 in combination with chemotherapy for CLDN18.2-positive gastric cancer and pancreatic cancer
This study tests whether adding IBI343 to standard chemotherapy helps people with CLDN18.2-positive advanced gastric/gastroesophageal junction cancer or pancreatic ductal cancer.
-
Combining Fruquintinib with chemotherapy for treating gastric cancer after surgery
This study is testing if adding Fruquintinib to standard chemotherapy can help people with HER2-negative gastric cancer who had surgery and are at high risk of their cancer coming back.
-
Combining paclitaxel, apatinib, and adebrelimab for advanced gastric cancer treatment
This study is testing a new combination of three drugs to see if it can help people with advanced stomach cancer who haven't had much success with other treatments.
-
Testing BMS-986340 alone and with other treatments for advanced solid tumors
This study is testing a new treatment called BMS-986340, both on its own and with other drugs, to see how safe it is for people with advanced solid tumors.
Related topics
Quick answers
How many Gastric/Gastroesophageal Junction Adenocarcinoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in China (3 trials), Australia (1 trial), Canada (1 trial), Germany (1 trial), Israel (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.